Risk compensation after COVID-19 vaccination: Evidence from vaccine rollout by exact birth date in South Korea.
Jisoo HwangSeung-Sik HwangHyuncheol Bryant KimJungmin LeeJunseok LeePublished in: Health economics (2024)
We utilize the phased rollout of COVID-19 vaccines by exact birth date in South Korea as a natural experiment for testing risk compensation. People may resume face-to-face social activities following vaccination because they perceive lower risk of infection. Applying a regression discontinuity design based on birth date cutoffs for vaccine eligibility, we find no evidence of risk-compensating behaviors, as measured by large, high-frequency data from credit card and airline companies as well as survey data. We find some evidence of self-selection into vaccine take-up based on perception toward vaccine effectiveness and side effects, but the treatment effects do not differ between compliers and never-takers.